Beauty Health Company ( (SKIN) ) has released its Q3 earnings. Here is a breakdown of the information Beauty Health Company presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The Beauty Health Company, a medtech meets beauty enterprise, is renowned for its flagship brand Hydrafacial, offering innovative skin health experiences through hydradermabrasion, nanoneedling, and microneedling technologies.
In its third-quarter financial report for 2025, Beauty Health Company reported revenues of $70.7 million, surpassing its guidance range, with an adjusted EBITDA of $8.9 million. Despite challenges in device sales, the company’s consumables business showed resilience, contributing to a stronger gross margin.
Key financial metrics revealed a 10.3% decrease in net sales compared to the previous year, primarily due to a decline in delivery systems sales. However, the gross margin improved to 64.6%, driven by a favorable sales mix and reduced inventory charges. The company’s net loss narrowed to $11.0 million, reflecting lower operational expenses and enhanced profitability.
Looking ahead, Beauty Health Company remains focused on expanding its device footprint and consumables growth, with an updated 2025 financial guidance projecting net sales between $293 and $300 million and adjusted EBITDA between $37 and $39 million, assuming stable market conditions.